Search research articles
Contact Us
Filters
Showing results (381-390 of 394) with videos related to
Page
of 40
Sort By:
The Journal of Investigative Dermatology
|
September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations
Josef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
The Journal of Clinical Investigation
|
July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares
James G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Laura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
The Journal of Rheumatology
|
June 15, 2024
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study
Dan E Webster, Rebecca H Haberman, Lourdes M Perez-Chada, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting
Sarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Journal of the American Academy of Dermatology
|
January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology
|
September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of Drugs in Dermatology : JDD
|
December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
Arianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
Journal of the American Academy of Dermatology
|
December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
April W Armstrong, Michael P Siegel, Jerry Bagel, et al.
The Journal of Rheumatology
|
August 1, 2023
Proceedings of the GRAPPA 2022 Executive Retreat
Beverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 394) with videos related to
Sort By:
Page
of 40
The Journal of Investigative Dermatology
|
September 24, 2018
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations
Josef Symon S Concha, Aikaterini Patsatsi, Ann Marshak-Rothstein, et al.
The Journal of Clinical Investigation
|
July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares
James G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Laura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
The Journal of Rheumatology
|
June 15, 2024
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study
Dan E Webster, Rebecca H Haberman, Lourdes M Perez-Chada, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting
Sarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Journal of the American Academy of Dermatology
|
January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology
|
September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of Drugs in Dermatology : JDD
|
December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting
Arianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
Journal of the American Academy of Dermatology
|
December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
April W Armstrong, Michael P Siegel, Jerry Bagel, et al.
The Journal of Rheumatology
|
August 1, 2023
Proceedings of the GRAPPA 2022 Executive Retreat
Beverly Cheok Kuan Ng, Deepak Jadon, Adewale Adebajo, et al.
Page
of 40